Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients

被引：0
|
作者：
K. Rossing
P. K. Christensen
P. Hovind
H.-H. Parving
机构：
[1] Steno Diabetes Center,Faculty of Health Science
[2] Aarhus University,undefined
来源：
Diabetologia | 2005年 / 48卷
关键词：
Albuminuria; Antihypertensive treatment; Blood pressure; Diabetic nephropathy; End-stage renal disease; Mortality; Nephrotic-range albuminuria; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2241 / 2247
页数：6
相关论文
共 50 条
  • [21] Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis
    Özdemir, BH
    Özdemir, FN
    Sezer, S
    Sar, A
    Haberal, M
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (02) : 432 - 434
  • [22] Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
    Wang, Tingli
    Zhang, Junlin
    Wang, Yiting
    Zhao, Lijun
    Wu, Yucheng
    Ren, Honghong
    Zou, Yutong
    Zhang, Rui
    Xu, Huan
    Chai, Zhonglin
    Cooper, Mark E.
    Zhang, Jie
    Liu, Fang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [23] Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy
    Alexander, CM
    Lyle, PA
    Keane, WF
    Carides, GW
    Zhang, ZX
    Shahinfar, S
    KIDNEY INTERNATIONAL, 2004, 66 : S115 - S117
  • [24] A Risk Prediction Model for End-Stage Renal Disease in Patients with Type 2 Diabetes Mellitus
    Geba, Daniela
    Cordova, Jeanine M.
    Shetty, Sharash
    Williams, Brent
    DIABETES, 2019, 68
  • [25] Risk Factors Associated with End-Stage Renal Disease in Type 2 Diabetes Mellitus Patients
    Putri, Suci Tuty
    4TH INTERNATIONAL VIRTUAL CONFERENCE ON NURSING, 2021, : 907 - 919
  • [26] Losartan reduces the burden and cost of diabetic end-stage renal disease in Greece
    Stafylas, P. C.
    Sarafidis, P. A.
    Lasaridis, A. N.
    Grekas, D. M.
    Dombros, N. V.
    Tsakni, E.
    Aletras, V. H.
    Niakas, D. A.
    Bakris, G. L.
    JOURNAL OF HYPERTENSION, 2006, 24 : S124 - S124
  • [27] Losartan reduces the costs of diabetic end-stage renal disease: An Asian perspective
    Seng, WK
    Hwang, SJ
    Han, DC
    Teong, CC
    Chan, J
    Burke, TA
    Carides, GW
    Choi, YJ
    NEPHROLOGY, 2005, 10 (05) : 520 - 524
  • [28] Impact of anemia on left ventricular remodeling in type 2 diabetic patients with end-stage renal disease
    Sato, A
    Aki, N
    Nagao, M
    Otake, S
    Nakagami, T
    Babazono, T
    Iwamoto, Y
    DIABETOLOGIA, 2005, 48 : A398 - A399
  • [29] Cardiac death in Japanese type 2 diabetic patients during end-stage renal disease therapy
    Sato, A
    Nakagami, T
    Tomonaga, O
    Babazono, T
    Iwamoto, Y
    DIABETOLOGIA, 1999, 42 : A264 - A264
  • [30] Minority advantage in diabetic end-stage renal disease survival on hemodialysis: Due to different proportions of diabetic type?
    Medina, RA
    Pugh, JA
    Monterrosa, A
    Cornell, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (02) : 226 - 234
12345